Plasma 25-hydroxyvitamin D concentration and lymphoma risk: Results of the european prospective investigation into cancer and nutrition

American Journal of Clinical Nutrition

Volumn 98, Issue 3, 2013, Pages 827-838

  Łuczyńska, Anna ^a   Kaaks, Rudolf ^b   Rohrmann, Sabine ^c   Becker, Susen ^b,d   Linseisen, Jakob ^e   Buijsse, Brian ^f   Overvad, Kim ^g   Trichopoulou, Antonia ^h,i   Valanou, Elisavet ⁱ   Barmpitsioti, Antonia ⁱ   Masala, Giovanna ^j   Agnoli, Claudia ^k   Tumino, Rosario ^l   Panico, Salvatore ^m   Bas Bueno de Mesquita, H ^n,o   Van Duijnhoven, Fränzel J B ^n,p   Peeters, Petra H M ^o,aj,ak   Vermeulen, Roel ^o,q   Weiderpass, Elisabete ^r,s,t,u   Brustad, Magritt ^r   Skeie, Guri ^r   González, Carlos A ^v   Jakszyn, Paula ^v   Ramon Quiros J ^w   Sánchez, María José ^x,y   Huerta, José María ^x,z   Ardanaz, Eva ^x,aa   Melin, Beatrice ^ab   Johansson, Ann Sofie ^ab   Almquist, Martin ^ac   Malm, Johan ^ad   Khaw, Kay Tee ^ae   Wareham, Nick ^af   Travis, Ruth C ^ag   Fedirko, Veronika ^ah,ai   Romieu, Isabelle ^ah   Jenab, Mazda ^ah   Gallo, Valentina ^aj,ak,al   Riboli, Elio ^aj,ak   Vineis, Paolo ^aj,ak   Nieters, Alexandra ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l Civile MP Arezzo Hospital   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁿ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p WAGENINGEN UNIVERSITY   (Netherlands)

^q UTRECHT UNIVERSITY   (Netherlands)

^r UNIVERSITY OF TROMSØ   (Norway)

^s CANCER REGISTRY OF NORWAY   (Norway)

^t KAROLINSKA INSTITUTE   (Sweden)

^u FOLKHÄLSAN RESEARCH CENTER   (Finland)

^v Environment and Cancer   (Spain)

^w Health and Health Care Services Council   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^z DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac LUND UNIVERSITY HOSPITAL   (Sweden)

^ad LUND UNIVERSITY   (Sweden)

^ae UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^af MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ai EMORY UNIVERSITY   (United States)

^aj IMPERIAL COLLEGE LONDON   (United Kingdom)

^ak QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^al Healthcare Iinnovation and Policy Unit   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY;

CASE-CONTROL STUDIES; CHRONIC DISEASE; COHORT STUDIES; DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOID; LOGISTIC MODELS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; VITAMIN D;

EID: 84883143983     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.054676     Document Type: Article

References (47)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117(19):5019-32.
3. Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. Vitamin D and non-Hodgkin lymphoma risk in adults: a review. Cancer Invest 2009;27:942-51.
4. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med 2008;264:537-48.
5. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer 1992;70:840-9.
6. Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994;14:387-94.
7. Armstrong BK, Kricker A. Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:396-400.
8. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-71.
9. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-Mac Donald A, Jensen BA, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97(3):199-209.
10. Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, Severson RK, Davis S. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006;17:1045-52.
11. Weihkopf T, Becker N, Nieters A, Mester B, Deeg E, Elsner G, Blettner M, Seidler A. Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 2007; 120:2445-51.
12. Veierød MB, Smedby KE, Lund E, Adami HO, Weiderpass E. Pigmentary characteristics, UV radiation exposure, and risk of non-Hodgkin lymphoma: a prospective study among Scandinavian women. Cancer Epidemiol Biomarkers Prev 2010;19:1569-76.
13. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjose S, Hartge P, Melbye M, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122:144-54.
14. Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, Clarke CA, Horn-Ross PL. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood 2011;118:1591-9.
15. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008;87:1087S-91S.
16. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179(3):1634-47.
17. Bruce D, Ooi JH, Yu S, Cantorna MT. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 2010;235:921-7.
18. Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009;124:979-86.
19. Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu XO, Stevens VL, et al. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010;172:58-69.
20. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5(6B):1113-24.
21. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology (Am Soc Hematol Educ Program) 2009;2009:523-31.
22. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982;116:547-53.
23. Cavalier E, Wallace AM, Carlisi A, Chapelle JP, Delanaye P, Souberbielle JC. Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clin Chem Lab Med 2011;49:555-8.
24. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009;55:1300-2.
25. Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008;168:1073-81.
26. Borkowf CB, Albert PS, Abnet CC. Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories. Stat Med 2003;22:1477-93.
27. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010;172:10-20.
28. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
29. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004;89-90:611-4.
30. Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS. Extra-renal 25-hydroxyvitamin D3-1alphahydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007;103:316-21.
31. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20:1352-60.
32. Shanafelt TD, Drake MT, Maurer MJ, Allmer C, Rabe KG, Slager SL, Weiner GJ, Call TG, Link BK, Zent CS, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011;117:1492-8.
33. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003;101:2454-60.
34. Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull 2008;87:49-62.
35. Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR, Engels EA. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007;109(5):2198-201.
36. Anderson LA, Landgren O, Engels EA. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 2009;147:444-9.
37. Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB, Peiris AN. Antimicrobial implications of vitamin D. Dermatoendocrinol 2011;3(4):220-9.
38. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 2011;106:1433-40.
39. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.169/4/384 [pii].
40. Camargo CA Jr, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, Sumberzul N, Rich-Edwards JW. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012;130:e561-7.
41. Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006;17:713-8.
42. Mikhak B, Bracci PM, Gong Z. Intake of vitamins D and A and calcium and risk of non-Hodgkin lymphoma: San Francisco Bay area population-based case-control study. Nutr Cancer 2012;64:674-84.
43. Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr 1999;18: 470-4.
44. Whiting SJ, Calvo MS. Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? Mol Nutr Food Res 2010;54:1077-84.
45. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011;25:671-80.
46. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007;103:620-5.
47. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010;171:903-8.